TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS

The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that...

Full description

Saved in:
Bibliographic Details
Main Authors FERREIRA DE MOURA LOURENÇO, Bianca Natália, TRAAS, Anne, Michelle, ERICKSON COLEMAN, Amanda, BROWN, Scott, Alan, CREEVY, Kate, Elizabeth
Format Patent
LanguageEnglish
French
German
Published 18.05.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.
Bibliography:Application Number: EP20200727049